Jacques Y Roberge (Jacques Roberge)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Escherichia Coli

Alcohol Use Disorder

Quality Control

Top Venues

Antibiotics (Basel, Switzerland)

ACS infectious diseases

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Rudolph, Anastasiia M Tsymbal, Arkajyoti Dutta, Simon A Davis, Benjamin Algava, Jacques Y Roberge, Nilgun E Tumer, Xiao-Ping Li
Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2. ACS infectious diseases 10 (8) (2024)
Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Michael J Rudolph, Anastasiia M Tsymbal, Arkajyoti Dutta, Simon A Davis, Benjamin Algava, Jacques Y Roberge, Nilgun E Tumer, Xiao-Ping Li
Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2. ACS infectious diseases (2024)
Eric J Bryan, Qi Qiao, Yuxuan Wang, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Michael J Rudolph, Anastasiia M Tsymbal, Arkajyoti Dutta, Simon A Davis, Benjamin Algava, Jacques Y Roberge, Nilgun E Tumer, Xiao-Ping Li
Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2. ACS infectious diseases 10 (8) (2024)
Bin Lu, Qi Qiao, Elizabeth R Park, Yuxuan Wang, John A Gilleran, Matthew Pan, Daniel S Pilch, Xiang Wu, Jacques Y Roberge, Huizhou Fan
Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency. ACS omega 8 (7) (2023)
Bin Lu, Qi Qiao, Elizabeth R Park, Yuxuan Wang, John A Gilleran, Matthew Pan, Daniel S Pilch, Xiang Wu, Jacques Y Roberge, Huizhou Fan
Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency. ACS omega 8 (7) (2023)
Eric J Bryan, Hye Yeon Sagong, Ajit K Parhi, Mark C Grier, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Eileen Carry, Dushyant Kshatriya, Joshua Silva, Daryl L Davies, Bo Yuan, Qingli Wu, Harna Patel, Elizabeth R Park, John Gilleran, Lihong Hao, Jacques Y Roberge, Nicholas T Bello, James E Simon
Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice. International journal of molecular sciences 22 (14) (2021)
Xiao-Ping Li, Rajesh K Harijan, Bin Cao, Jennifer N Kahn, Michael Pierce, Anastasiia M Tsymbal, Jacques Y Roberge, David Augeri, Nilgun E Tumer
Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design. Journal of medicinal chemistry 64 (20) (2021)
Joshua Silva, Eileen Carry, Chen Xue, Jifeng Zhang, Jing Liang, Jacques Y Roberge, Daryl L Davies
A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice. Molecules (Basel, Switzerland) 26 (6) (2021)
John A Gilleran, Xin Yu, Alan J Blayney, Anthony F Bencivenga, Bing Na, David J Augeri, Adam R Blanden, S David Kimball, Stewart N Loh, Jacques Y Roberge, Darren R Carpizo
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53. Journal of medicinal chemistry 64 (4) (2021)